Jesús Medina

2.4k total citations · 1 hit paper
62 papers, 1.6k citations indexed

About

Jesús Medina is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jesús Medina has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 20 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Surgery. Recurrent topics in Jesús Medina's work include Acute Myocardial Infarction Research (22 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers) and Diabetes Treatment and Management (13 papers). Jesús Medina is often cited by papers focused on Acute Myocardial Infarction Research (22 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers) and Diabetes Treatment and Management (13 papers). Jesús Medina collaborates with scholars based in Spain, United Kingdom and France. Jesús Medina's co-authors include Stuart Pocock, Frans Van de Werf, Héctor Bueno, Kamlesh Khunti, Peter Fenici, Niklas Hammar, Kyle McBride, М. В. Шестакова, Marília Brito Gomes and Nicolas Danchin and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Diabetes.

In The Last Decade

Jesús Medina

59 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review

2017 263 citations Kamlesh Khunti, Marília Brito Gomes et al. Diabetes Obesity and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesús Medina Spain	24	582	491	239	224	196	62	1.6k
Björn O. Eriksen Norway	33	701 1.2×	440 0.9×	290 1.2×	377 1.7×	146 0.7×	99	3.5k
Tae Ik Chang South Korea	25	277 0.5×	232 0.5×	298 1.2×	208 0.9×	118 0.6×	109	1.9k
Arnaud D. Kazé United States	21	313 0.5×	314 0.6×	284 1.2×	274 1.2×	152 0.8×	62	1.6k
Jula K. Inrig United States	27	964 1.7×	124 0.3×	494 2.1×	190 0.8×	133 0.7×	52	2.7k
Michelle M. Estrella United States	32	451 0.8×	324 0.7×	372 1.6×	535 2.4×	149 0.8×	182	3.6k
Gregory L. Braden United States	23	296 0.5×	161 0.3×	400 1.7×	216 1.0×	108 0.6×	91	2.5k
Ann Marie Navar‐Boggan United States	10	313 0.5×	220 0.4×	513 2.1×	146 0.7×	103 0.5×	17	1.1k
Chi‐Bon Leung Hong Kong	29	288 0.5×	172 0.4×	459 1.9×	193 0.9×	104 0.5×	69	2.5k
S Harikrishnan India	24	1.1k 1.8×	160 0.3×	420 1.8×	467 2.1×	110 0.6×	159	1.9k
Samira Bell United Kingdom	22	274 0.5×	203 0.4×	339 1.4×	210 0.9×	86 0.4×	78	1.9k

Countries citing papers authored by Jesús Medina

Since Specialization

Citations

This map shows the geographic impact of Jesús Medina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Medina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Medina more than expected).

Fields of papers citing papers by Jesús Medina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Medina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Medina. The network helps show where Jesús Medina may publish in the future.

Co-authorship network of co-authors of Jesús Medina

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Medina. A scholar is included among the top collaborators of Jesús Medina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Medina. Jesús Medina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quintero, Javier, et al.. (2025). A survey of knowledge and perceptions of ADHD and autism spectrum disorder in the workplace at a large corporation. Scientific Reports. 15(1). 34424–34424.

Bongaerts, Brenda, Oliver Kuß, Fabrice Bonnet, et al.. (2023). HbA1c trajectories over 3 years in people with type 2 diabetes starting second‐line glucose‐lowering therapy: The prospective global DISCOVER study. Diabetes Obesity and Metabolism. 25(7). 1890–1899. 2 indexed citations

González‐Del‐Hoyo, Maribel, Xavier Rosselló, Vicente Peral, et al.. (2023). Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality: Insights from an international cohort of 23,489 patients with acute coronary syndrome. American Heart Journal. 264. 20–30. 6 indexed citations

Hejjaji, Vittal, Juan José Gorgojo Martínez, Fengming Tang, et al.. (2022). Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study. Diabetes Obesity and Metabolism. 24(9). 1734–1740. 2 indexed citations

Khunti, Kamlesh, B Charbonnel, Hungta Chen, et al.. (2021). Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study. Diabetes Obesity and Metabolism. 23(8). 1956–1960. 13 indexed citations

Rosselló, Xavier, Stuart Pocock, Lourdes Vicent, et al.. (2021). Sex differences in mortality after an acute coronary syndrome increase with lower country wealth and higher income inequality. Revista Española de Cardiología (English Edition). 75(5). 392–400. 5 indexed citations

Khunti, Kamlesh, Linong Ji, Jesús Medina, Filip Surmont, & Mikhail Kosiborod. (2019). Type 2 diabetes treatment and outcomes worldwide: A short review of the DISCOVER study programme. Diabetes Obesity and Metabolism. 21(11). 2349–2353. 13 indexed citations

Gomes, Marília Brito, Fengming Tang, Hungta Chen, et al.. (2019). 1279-P: Socioeconomic Factors Associated with Poor Glycemic Control in People with Type 2 Diabetes: The DISCOVER Study. Diabetes. 68(Supplement_1). 1 indexed citations

Wilding, John, Thomas Godec, Kamlesh Khunti, et al.. (2018). Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. BMC Medicine. 16(1). 116–116. 40 indexed citations

10.

Rosselló, Xavier, Héctor Bueno, Stuart Pocock, et al.. (2018). Predictors of all‐cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry. Clinical Cardiology. 42(1). 111–119. 42 indexed citations

11.

Ponte‐Negretti, Carlos I., Fernando Laņas, Jesús Medina, et al.. (2017). Dislipidemia aterogénica en Latinoamérica: prevalencia, causas y tratamiento. Un consenso. 28(2). 54–85.

12.

Khunti, Kamlesh, Marília Brito Gomes, Stuart Pocock, et al.. (2017). Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review. Diabetes Obesity and Metabolism. 20(2). 427–437. 263 indexed citations breakdown →

13.

Borghi, Claudio, Florence Tubach, Guy De Backer, et al.. (2016). Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study. International Journal of Cardiology. 218. 83–88. 74 indexed citations

14.

Borghi, Claudio, Fernando Rodríguez‐Artalejo, Guy De Backer, et al.. (2016). The association between blood pressure and lipid levels in Europe. Journal of Hypertension. 34(11). 2155–2163. 19 indexed citations

15.

Halcox, Julian, Florence Tubach, Esther López‐García, et al.. (2015). Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe. PLoS ONE. 10(2). e0115270–e0115270. 22 indexed citations

16.

Bueno, Héctor, Peter Sinnaeve, Lieven Annemans, et al.. (2015). Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns. European Heart Journal Acute Cardiovascular Care. 5(1). 3–12. 33 indexed citations

17.

Ostermann, Helmut, et al.. (2014). Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study. BMC Pulmonary Medicine. 14(1). 36–36. 23 indexed citations

18.

Halcox, Julian, Carine Roy, Florence Tubach, et al.. (2014). C-reactive protein levels in patients at cardiovascular risk: EURIKA study. BMC Cardiovascular Disorders. 14(1). 25–25. 40 indexed citations

19.

Pocock, Stuart, Héctor Bueno, Muriel Licour, et al.. (2014). Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study. European Heart Journal Acute Cardiovascular Care. 4(6). 509–517. 70 indexed citations

20.

Garau, Javier, et al.. (2013). Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study. Clinical Microbiology and Infection. 19(9). E377–E385. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact